Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Hepatitis B 1Gallstones 1Depression 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Sorafenib 9gadolinium ethoxybenzyl DTPA 4Hepatectomy 4lenvatinib 3entecavir 3Sufentanil 3Ribavirin 3Propranolol 3Lamivudine 3sofosbuvir-velpatasvir drug combination 2peginterferon alfa-2a 2gadoterate meglumine 2atezolizumab 2Thrombectomy 2Tenofovir 2Sevoflurane 2Radiofrequency Ablation 2Laparoscopy 2Esketamine 2Chemoembolization, Therapeutic 2Bevacizumab 2xihuang 1stronger neominophagen C 1ledipasvir 1huaier 1halofantrine 1gadoteridol 1gadodiamide 1gadobutrol 1gadobenic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Hepatocellular × Hepatitis B Vaccines × Clear all
NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Eunice Dube

Phase 4 Not yet recruiting
1,800 enrolled
GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

Data powered by HemOnc (CC BY 4.0) Colophon âš¡